東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Strategies for combined screening an...

Warram, Jason M.

FindBook

Google Book

Amazon

博客來

Strategies for combined screening and imaging of breast cancer .

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Strategies for combined screening and imaging of breast cancer ./
作者:	Warram, Jason M.
面頁冊數:	122 p.
附註:	Source: Dissertation Abstracts International, Volume: 72-08, Section: B, page: .
Contained By:	Dissertation Abstracts International72-08B.
標題:	Health Sciences, Pathology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3457206
ISBN:	9781124673189

Strategies for combined screening and imaging of breast cancer .
Warram, Jason M.

Strategies for combined screening and imaging of breast cancer . - 122 p.

Source: Dissertation Abstracts International, Volume: 72-08, Section: B, page: .

Thesis (Ph.D.)--The University of Alabama at Birmingham, 2011.

Successful treatment of breast cancer directly correlates with tumor stage and grade at diagnosis. Early diagnosis leads to a five-year relative survival rate of 96.8% as opposed to only a 22.5% five-year survival rate when diagnosed at late stage. Cancer-specific mechanisms need to be extended to enable cancer detection in an individual patient, in particular, the metastatic burden that currently cannot be assessed by conventional imaging. This approach for cancer detection would remove the biases of patient characteristics, permit immediate diagnostic feedback, improve sensitivity for early detection of small metastatic lesions, and be cost effective. Toward this goal, the cancer-specific diagnostic adenovirus (Ad) vector (Ad5/3-Id1-SEAP-Id1-mCherry) was produced that includes a human secreted embryonic alkaline phosphatase (SEAP) reporter for blood-based screening and a fluorescent reporter (mCherry) for localized imaging. Importantly, the cancer-specific promoter Id1 was selected to drive both reporters due to the correlation between aggressive cancer phenotypes and high Id1 expression. Safety and efficacy issues have limited the use of recombinant Ad for routine clinical applications. To overcome this impediment, ultrasound microbubbles (MB) were developed to improve Ad delivery to the tumor vasculature. This was achieved by targeting the Ad packaged MB to receptors overexpressed in the tumor, namely alphaVbeta3 integrin, P-selectin, and VEGFR2. During in vitro assessment, both SEAP and mCherry reporter expression was shown to correlate with cancer cell phenotype. In a tumor-bearing mouse model, SEAP reporter expression was found to be 14-fold over background when as little as 2.5% of tumor cells were infected. Triple-targeted MBs displayed enhanced affinity for tumor vasculature when assessed in vitro and in vivo. Packaging of the targeted MBs with diagnostic Ad was confirmed and the approach was tested in a tumor-bearing mouse model. Groups receiving the targeted Ad packaged MBs displayed a 4-fold increase in SEAP reporter expression over groups receiving equivalent unpackaged Ad dosing. In addition, the mCherry fluorescence reporter was localized in the tumor. Safe delivery of a non-invasive diagnostic reporter system using FDA approved MBs has the potential for immediate application, allowing this diagnostic system to impact populations currently in need of more advanced and sensitive detection modalities.

ISBN: 9781124673189Subjects--Topical Terms:

1017854
Health Sciences, Pathology.

Strategies for combined screening and imaging of breast cancer .
LDR:03761nam 2200349 4500 001 1405569
005 20111219143105.5
008 130515s2011 ||||||||||||||||| ||eng d
020 $a 9781124673189
035 $a (UMI)AAI3457206
035 $a AAI3457206
040 $a UMI $c UMI
100 1 $a Warram, Jason M. $3 1684959
245 1 0 $a Strategies for combined screening and imaging of breast cancer .
300 $a 122 p.
500 $a Source: Dissertation Abstracts International, Volume: 72-08, Section: B, page: .
500 $a Adviser: Kurt R. Zinn.
502 $a Thesis (Ph.D.)--The University of Alabama at Birmingham, 2011.
520 $a Successful treatment of breast cancer directly correlates with tumor stage and grade at diagnosis. Early diagnosis leads to a five-year relative survival rate of 96.8% as opposed to only a 22.5% five-year survival rate when diagnosed at late stage. Cancer-specific mechanisms need to be extended to enable cancer detection in an individual patient, in particular, the metastatic burden that currently cannot be assessed by conventional imaging. This approach for cancer detection would remove the biases of patient characteristics, permit immediate diagnostic feedback, improve sensitivity for early detection of small metastatic lesions, and be cost effective. Toward this goal, the cancer-specific diagnostic adenovirus (Ad) vector (Ad5/3-Id1-SEAP-Id1-mCherry) was produced that includes a human secreted embryonic alkaline phosphatase (SEAP) reporter for blood-based screening and a fluorescent reporter (mCherry) for localized imaging. Importantly, the cancer-specific promoter Id1 was selected to drive both reporters due to the correlation between aggressive cancer phenotypes and high Id1 expression. Safety and efficacy issues have limited the use of recombinant Ad for routine clinical applications. To overcome this impediment, ultrasound microbubbles (MB) were developed to improve Ad delivery to the tumor vasculature. This was achieved by targeting the Ad packaged MB to receptors overexpressed in the tumor, namely alphaVbeta3 integrin, P-selectin, and VEGFR2. During in vitro assessment, both SEAP and mCherry reporter expression was shown to correlate with cancer cell phenotype. In a tumor-bearing mouse model, SEAP reporter expression was found to be 14-fold over background when as little as 2.5% of tumor cells were infected. Triple-targeted MBs displayed enhanced affinity for tumor vasculature when assessed in vitro and in vivo. Packaging of the targeted MBs with diagnostic Ad was confirmed and the approach was tested in a tumor-bearing mouse model. Groups receiving the targeted Ad packaged MBs displayed a 4-fold increase in SEAP reporter expression over groups receiving equivalent unpackaged Ad dosing. In addition, the mCherry fluorescence reporter was localized in the tumor. Safe delivery of a non-invasive diagnostic reporter system using FDA approved MBs has the potential for immediate application, allowing this diagnostic system to impact populations currently in need of more advanced and sensitive detection modalities.
520 $a Keywords: breast cancer, screening, gene therapy, microbubbles, ultrasound contrast agent, adenovirus delivery.
590 $a School code: 0005.
650 4 $a Health Sciences, Pathology. $3 1017854
690 $a 0571
710 2 $a The University of Alabama at Birmingham. $b Pathology. $3 1684960
773 0 $t Dissertation Abstracts International $g 72-08B.
790 1 0 $a Zinn, Kurt R., $e advisor
790 1 0 $a Borovjagin, Anton V. $e committee member
790 1 0 $a Feng, Xu $e committee member
790 1 0 $a Frost, Andra R. $e committee member
790 1 0 $a Lopez, Richard D. $e committee member
790 1 0 $a Ponnazhagan, Selvarangan $e committee member
790 1 0 $a Sanderson, Ralph D. $e committee member
790 $a 0005
791 $a Ph.D.
792 $a 2011
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3457206